ArticlePloS one2021

Dynamics of patents, orphan drug designation, licensing, and revenues from drugs for rare diseases: The market expansion of eculizumab.

Rosângela Caetano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.